DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Quinacrine is an investigational drug.
There have been 9 clinical trials for Quinacrine. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2005.
The most common disease conditions in clinical trials are Glioblastoma, Carcinoma, Non-Small-Cell Lung, and Creutzfeldt-Jakob Syndrome. The leading clinical trial sponsors are Cleveland BioLabs, University of California, San Francisco, and Milton S. Hershey Medical Center.
Recent Clinical Trials for Quinacrine
|The Efficacy of OK-432 Pleurodesis on Postoperative Air Leak||National Taiwan University Hospital||N/A|
|Quinacrine-Capecitabine Combinatorial Therapy for Advanced Stage Colorectal ADenocarcinoma||Milton S. Hershey Medical Center||Phase 1/Phase 2|
|Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung Cancer||Neelesh Sharma MD PhD||Phase 1|